It targets GIP, GLP-1, and glucagon pathways
Only FDA-approved medications (Mounjaro and Zepbound) are now available for most patients
Semaglutide is believed to mimic the GLP-1 hormone, which may: Help reduce appetite and food cravings in some patients Slow the rate of gastric emptying Promote a feeling of fullness Assist in regulating blood sugar levels The degree of these effects may vary considerably between individuals
When storing semaglutide at room temperature, patients should keep the pen away from direct heat sources, such as radiators, stoves, or direct sunlight, and avoid storing it in vehicles where temperatures can fluctuate dramatically
The study also found that after semaglutide intervention, the food intake of obese mice decreased significantly, achieved by regulating appetite-related factors in the hypothalamus, indicating that semaglutide could penetrate the blood-brain barrier to reach the hypothalamus, brainstem, and arcuate nucleus through peripheral administration (Martins et al., 2022)